Sleep apnoea: no obstruction to international travel.,Journal of Travel Medicine

当前位置： X-MOL 学术 › J. Travel Med. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Sleep apnoea: no obstruction to international travel.
Journal of Travel Medicine ( IF 9.1 ) Pub Date : 2020-05-19 , DOI: 10.1093/jtm/taaa078
Sinead M Walsh _{1,

2} , Gerard T Flaherty _{1,

3}

Affiliation

Obstructive sleep apnoea syndrome (OSAS) is the most prevalent chronic respiratory condition. The prevalence of OSAS has increased substantially in recent times, largely due to its strong association with obesity. Obesity, particularly the accumulation of adipose tissue in the neck, is a major risk factor for OSAS. At present, OSAS (defined as an apnoea–hypopnoea index > 5) is estimated to affect 20–30% of males and 10–15% of females in developed countries.¹ There are few data on prevalence in developing countries. Despite the increasing prevalence of OSAS, there is a paucity of guidance in the literature in relation to issues surrounding international travel in individuals with OSAS. This perspective on the topic was generated from the available literature and the clinical experience of the authors.

更新日期：2020-07-14

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南11